A Study of Nivolumab and Intrapleural Talimogene Laherparepvec for Malignant Pleural Effusion
Status:
Terminated
Trial end date:
2020-02-12
Target enrollment:
Participant gender:
Summary
This is a Phase Ib/II clinical trial to evaluate the feasibility of administering talimogene
laherparepvec into the intrapleural space of subjects with malignant pleural effusion through
a pleurX catheter.